Prostate Cancer Clinical Trials

A listing of Prostate Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1151 clinical trials
Radium-223 in Biochemically Recurrent Prostate Cancer

Background Some men who have been treated for localized prostate cancer with surgery or radiation still show signs of the disease in their blood. This is called

  • 0 views
  • 27 Jun, 2022
  • 1 location
NY-ESO Phase I Study for Prostate Cancer

Prostate cancer is the most common type of cancer found in American men, other than skin cancer. The American Cancer Society estimates that there will be about 218,890 new cases of

  • 142 views
  • 07 Nov, 2020
  • 1 location
Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy

In the clinical scenario of recurrent prostate cancer (PCa) post local therapy, current standard studies (bone scan and computed tomography) commonly fail to identify the recurrent disease

  • 5 views
  • 24 Mar, 2022
  • 1 location
Focal Radiotherapy for Previously Treated Prostate Cancer Patients

To examine the feasibility, safety and toxicity of focal stereotactic radiation treatment (SBRT) for locally recurrent prostate cancer.

  • 2 views
  • 25 Mar, 2022
  • 1 location
PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA (PROTRACT)

enzalutamide, and ctDNA fraction ≥2% receives docetaxel) versus clinician's choice of enzalutamide or docetaxel, in subjects with metastatic castration-resistant prostate cancer post abiraterone setting.

platelet count
docetaxel
neutrophil count
orchiectomy
conjugated bilirubin
  • 0 views
  • 24 Mar, 2022
  • 4 locations
Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer

Primary To evaluate the safety and tolerability of ADXS-504 and to determine the MTD or RP2D.

  • 0 views
  • 20 Oct, 2021
  • 1 location
Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer

A two arm, multi centric, randomized, open label, parallel, two doses pharmacodynamics study in patients with advanced prostate cancer.

  • 0 views
  • 22 Mar, 2022
  • 1 location
Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer

PERSEUS1 is an open-label, single arm, phase II trial evaluating the efficacy of Pembrolizumab in metastatic castration resistant prostate cancer (mCRPC) patients (Part A) with a biomarker

platelet count
antiandrogens
docetaxel
neutrophil count
adenocarcinoma of prostate
  • 0 views
  • 24 Jan, 2021
  • 1 location
GE-148-002: A Phase 2 Open-label Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer

Background: - GE-148 (18F) is a new drug that is designed to attach to prostate cancer cells. Researchers are interested in combining the drug with a small amount of radioactive material

  • 36 views
  • 08 Nov, 2020
  • 1 location
  • 0 views
  • 19 Jun, 2022
  • 4 locations